Search

everythinglearnresearchcommunity

for

Search:↓

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Obesity is linked to more severe lower urinary tract symptoms.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

Children with partial biotinidase deficiency are healthy at birth but may develop symptoms that improve with biotin therapy.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Biotin deficiency in patients on total parenteral nutrition can cause serious symptoms but can be treated with biotin supplements.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Higher fluoride levels may delay puberty in boys.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Finasteride has different absorption and metabolism in male and female rats, with higher concentrations in certain organs and mostly excreted through feces.